F. Vondung

Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients

W. Klapper, S. Szymczak, C. Schem, 2019, Journal of Molecular Medicine.

Cytoplasmic levels of high mobility group A2 determine survival prognoses in breast cancer patients

W. Klapper, C. Schem, I. Alkatout, 2020, The International journal of biological markers.

Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients

W. Klapper, S. Szymczak, C. Schem, 2019, Journal of Molecular Medicine.